Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Immunocore initiates phase 1 study of IMCnyeso in patients with solid tumors
Image: Immunocore doses first patient in phase 1 ImmTAC study in patients with solid tumors. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.
Image: Immunocore doses first patient in phase 1 ImmTAC study in patients with solid tumors. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.